Publications by authors named "XuanXuan Pan"

Claim this Profile
F
Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming.
Congyi Niu, Huan Wei, Xuanxuan Pan, Yuedi Wang, Huan Song

Cell Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomy.
Qing Zhang, XuanXuan Pan, Zhuajin Bi, Jiayang Zhan, Mengge Yang

Ther Adv Neurol Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy.
Huan Song, Lin Chen, Xuanxuan Pan, Yuru Shen, Maolin Ye

Cancer Cell· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rg3-lipo biomimetic delivery of paclitaxel enhances targeting of tumors and myeloid-derived suppressor cells.
Yuru Shen, Bin Zhong, Wanwei Zheng, Dan Wang, Lin Chen, Xuanxuan Pan

J Clin Invest· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy.
Wenshuai Li, Xuanxuan Pan, Lirong Chen, Haoshu Cui, Shaocong Mo, Yida Pan

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Identification of metabolites of Chenxiang Huaqi pill in rats based on UPLC-Q-TOF-MS].
Xuan-Xuan Pan, Fen-Yun Song, Xiu-Lian Lin, Hua Li

Zhongguo Zhong Yao Za Zhi· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis